Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Interest & Investment Income (2022 - 2026)

Lucid Diagnostics filings provide 4 years of Interest & Investment Income readings, the most recent being $110000.0 for Q4 2025.

  • On a quarterly basis, Interest & Investment Income rose 66.67% to $110000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $387000.0, a 20.19% increase, with the full-year FY2025 number at $386000.0, up 19.88% from a year prior.
  • Interest & Investment Income hit $110000.0 in Q4 2025 for Lucid Diagnostics, up from $101000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $136000.0 in Q2 2023 to a low of $1000.0 in Q1 2022.
  • Median Interest & Investment Income over the past 4 years was $79500.0 (2023), compared with a mean of $76312.5.
  • Biggest five-year swings in Interest & Investment Income: soared 7700.0% in 2023 and later plummeted 30.17% in 2024.
  • Lucid Diagnostics' Interest & Investment Income stood at $55000.0 in 2022, then surged by 70.91% to $94000.0 in 2023, then dropped by 29.79% to $66000.0 in 2024, then surged by 66.67% to $110000.0 in 2025.
  • The last three reported values for Interest & Investment Income were $110000.0 (Q4 2025), $101000.0 (Q3 2025), and $110000.0 (Q2 2025) per Business Quant data.